Quick Answer
LakeShore Biopharma Co., Ltd. reported Total Revenue of $85.67 million for the year ending 2025.
- LakeShore Biopharma Co., Ltd. showed a decrease of -85.1% in Total Revenue from 2024 to 2025.
- This data is from LakeShore Biopharma Co., Ltd.'s annual report (Form 10-K), filed with the SEC on July 31, 2025.
- XBRL data for this metric is available from 2021 to 2025 (5 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 5 years of available data (2021 to 2025), LakeShore Biopharma Co., Ltd.'s Total Revenue has declined by 66.7%.
- Historical annual values: Fiscal year 2025: $85.67 million | Fiscal year 2024: $573.42 million | Fiscal year 2023: $687.20 million | Fiscal year 2022: $502.95 million | Fiscal year 2021: $257.02 million.
- Data sourced from SEC EDGAR public filings as of August 10, 2026.
Last verified: